Cyclo Therapeutics Inc
NASDAQ:CYTH

Watchlist Manager
Cyclo Therapeutics Inc Logo
Cyclo Therapeutics Inc
NASDAQ:CYTH
Watchlist
Price: 0.74 USD 4.23% Market Closed
Market Cap: 21.2m USD
Have any thoughts about
Cyclo Therapeutics Inc?
Write Note

Wall Street
Price Targets

CYTH Price Targets Summary
Cyclo Therapeutics Inc

Wall Street analysts forecast CYTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CYTH is 0.97 USD with a low forecast of 0.96 USD and a high forecast of 1 USD.

Lowest
Price Target
0.96 USD
30% Upside
Average
Price Target
0.97 USD
31% Upside
Highest
Price Target
1 USD
35% Upside

CYTH Last Price Targets
Cyclo Therapeutics Inc

The latest public price target was made on Aug 26, 2024 by Lucas Ward from Ascendiant , who expects CYTH stock to rise by 28% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Lucas Ward
Ascendiant
0.95 USD
Upside 28%
2 months ago
Aug 26, 2024
Cyclo Therapeutics (CYTH) PT Lowered to $0.95 at Ascendiant Capital
StreetInsider
Lucas Ward
Ascendiant
Price Target 0.95 USD
Upside/Downside 28%
View Source
Cyclo Therapeutics Inc Competitors:
Price Targets
SGMT
Sagimet Biosciences Inc
460% Upside
BONEX
Bonesupport Holding AB
7% Downside
2162
KeyMed Biosciences Inc
40% Upside
002252
Shanghai RAAS Blood Products Co Ltd
10% Downside
300142
Walvax Biotechnology Co Ltd
17% Upside
STTK
Shattuck Labs Inc
62% Upside
QURE
Uniqure NV
191% Upside
SRZN
Surrozen Inc
240% Upside

Revenue
Forecast

Revenue Estimate
Cyclo Therapeutics Inc

For the last 8 years the compound annual growth rate for Cyclo Therapeutics Inc's revenue is 2%. The projected CAGR for the next 3 years is 140%.

2%
Past Growth
140%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Cyclo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Cyclo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYTH's stock price target?
Price Target
0.97 USD

According to Wall Street analysts, the average 1-year price target for CYTH is 0.97 USD with a low forecast of 0.96 USD and a high forecast of 1 USD.

What is Cyclo Therapeutics Inc's Revenue forecast?
Projected CAGR
140%

For the last 8 years the compound annual growth rate for Cyclo Therapeutics Inc's revenue is 2%. The projected CAGR for the next 3 years is 140%.

Back to Top